Molecular Screening for Lynch Syndrome in Denmark
Launched by VEJLE HOSPITAL · Apr 30, 2013
Trial Information
Current as of May 15, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Histological diagnosis of colorectal adenocarcinoma
- • Diagnosed at one of the departments of pathology in Denmark
- Exclusion Criteria:
- • None
About Vejle Hospital
Vejle Hospital is a leading healthcare institution in Denmark, dedicated to advancing medical research and enhancing patient care through innovative clinical trials. With a focus on multidisciplinary collaboration, Vejle Hospital leverages its state-of-the-art facilities and experienced research teams to conduct rigorous studies across various therapeutic areas. Committed to ethical standards and patient safety, the hospital aims to contribute valuable insights to the medical community, ultimately improving treatment outcomes and healthcare practices. Through its clinical trial initiatives, Vejle Hospital strives to foster a culture of scientific excellence and drive advancements in health and medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vejle, , Denmark
Esbjerg, , Denmark
Odense, , Denmark
Odense, , Denmark
Sønderborg, , Denmark
Vejle, , Denmark
Vejle, , Denmark
Aalborg, , Denmark
Aarhus, , Denmark
Aarhus, , Denmark
Hjørring, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials